These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21366826)

  • 21. [In vitro dexamethasone release from nanoparticles and its pharmacokinetics in the inner ear after administration of the drug-loaded nanoparticles via the round window].
    Chen G; Hou SX; Hu P; Hu QH; Guo DD; Xiao Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1022-4. PubMed ID: 18583254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops. Aqueous humor pharmacokinetics in humans.
    Kristinsson JK; Fridriksdóttir H; Thórisdóttir S; Sigurdardóttir AM; Stefánsson E; Loftsson T
    Invest Ophthalmol Vis Sci; 1996 May; 37(6):1199-203. PubMed ID: 8631635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of Mechanistic Ocular Absorption Modeling and Simulation to Understand the Impact of Formulation Properties on Ophthalmic Bioavailability in Rabbits: a Case Study Using Dexamethasone Suspension.
    Le Merdy M; Fan J; Bolger MB; Lukacova V; Spires J; Tsakalozou E; Patel V; Xu L; Stewart S; Chockalingam A; Narayanasamy S; Rouse R; Matta M; Babiskin A; Kozak D; Choi S; Zhang L; Lionberger R; Zhao L
    AAPS J; 2019 May; 21(4):65. PubMed ID: 31111305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of iontophoresis current magnitude and duration on dexamethasone deposition and localized drug retention.
    Anderson CR; Morris RL; Boeh SD; Panus PC; Sembrowich WL
    Phys Ther; 2003 Feb; 83(2):161-70. PubMed ID: 12564951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-inflammatory effectiveness of topically administered corticosteroids in the cornea without epithelium.
    Kupferman A; Leibowitz HM
    Invest Ophthalmol; 1975 Mar; 14(3):252-5. PubMed ID: 1116925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intratympanic dexamethasone as initial therapy for idiopathic sudden sensorineural hearing loss: Clinical evaluation and laboratory investigation.
    Fu Y; Zhao H; Zhang T; Chi F
    Auris Nasus Larynx; 2011 Apr; 38(2):165-71. PubMed ID: 20817429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Studies on the distribution of locally applied steroids in the eye].
    Draeger J
    Klin Monbl Augenheilkd; 1967; 150(4):546-9. PubMed ID: 5597900
    [No Abstract]   [Full Text] [Related]  

  • 28. Ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension for the topical treatment of ear infections: a review of the literature.
    Wall GM; Stroman DW; Roland PS; Dohar J
    Pediatr Infect Dis J; 2009 Feb; 28(2):141-4. PubMed ID: 19116600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Eye ointments eubetal and colbiocin in the treatment of chlamydial conjunctivitis].
    Maĭchuk IuF; Vakhova ES
    Vestn Oftalmol; 1998; 114(2):32-4. PubMed ID: 9621818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of a drug delivery system to a steroidal ophthalmic preparation with lipid microspheres.
    Yanagawa A; Mizushima Y; Komatsu A; Horiuchi M; Shirasawa E; Igarashi R
    J Microencapsul; 1987; 4(4):329-31. PubMed ID: 3504514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Regularities of drug desorption from soft contact lenses. 2. In vitro study].
    Rybakova EG; Avetisov SE; Badun GA; Krasnianskiĭ AV
    Vestn Oftalmol; 1996; 112(1):18-20. PubMed ID: 8659062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioavailability of hydrocortisone acetate from ophthalmic ointments.
    Umer S
    Acta Pol Pharm; 1994; 51(1):39-43. PubMed ID: 7976432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient compliance with use of topical ophthalmic corticosteroid suspensions.
    Apt L; Henrick A; Silverman LM
    Am J Ophthalmol; 1979 Feb; 87(2):210-4. PubMed ID: 434075
    [No Abstract]   [Full Text] [Related]  

  • 34. Physiologically Based Pharmacokinetic Model to Support Ophthalmic Suspension Product Development.
    Le Merdy M; Tan ML; Babiskin A; Zhao L
    AAPS J; 2020 Jan; 22(2):26. PubMed ID: 31907674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-efficacy site-directed drug delivery system using sialyl-Lewis X conjugated liposome.
    Hashida N; Ohguro N; Yamazaki N; Arakawa Y; Oiki E; Mashimo H; Kurokawa N; Tano Y
    Exp Eye Res; 2008 Jan; 86(1):138-49. PubMed ID: 18036523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized double-blind, positive-control trial of topical thalidomide in erosive oral lichen planus.
    Wu Y; Zhou G; Zeng H; Xiong CR; Lin M; Zhou HM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Aug; 110(2):188-95. PubMed ID: 20659697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ophthalmic ointments.
    Robin JS; Ellis PP
    Surv Ophthalmol; 1978; 22(5):335-40. PubMed ID: 653578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topically administered corticosteroids and treatment of inflammatory keratitis.
    Leibowitz HM; Kupferman A
    Invest Ophthalmol; 1975 May; 14(5):337-40. PubMed ID: 1126821
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of dimethyl sulfoxide on ocular inflammation.
    Hanna C; Fraunfelder FT; Meyer SM
    Ann Ophthalmol; 1977 Jan; 9(1):61-5. PubMed ID: 319730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A relevant choice for corticoid eye drops: solution or suspension?].
    Nourry H; Viard C; Cambourieu C; Warnet JM
    J Fr Ophtalmol; 2011 Dec; 34(10):691-6. PubMed ID: 22001623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.